Protagonist Therapeutics, Inc Other Receivables, Net, Current
Protagonist Therapeutics, Inc (PTGX) had Other Receivables, Net, Current of $11.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Notes › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2023-08-03
- 2023-06-30: Other Receivables, Net, Current $11.00K.
- 2022-12-31: Other Receivables, Net, Current $42.00K.
- 2022-09-30: Other Receivables, Net, Current $495.00K.
- 2022-06-30: Other Receivables, Net, Current $672.00K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2023-06-30 | $11.00K 10-Q · filed 2023-08-03 |
| 2022-12-31 | $42.00K 10-Q · filed 2023-08-03 |
| 2022-09-30 | $495.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $672.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $476.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $975.00K 10-K · filed 2023-03-15 |
| 2020-12-31 | $311.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $744.00K 10-K · filed 2021-03-10 |
| 2018-12-31 | $495.00K 10-K · filed 2020-03-10 |
| 2017-12-31 | $135.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |